Logo image of SELX

SEMILUX INTERNATIONAL LTD (SELX) Stock Fundamental Analysis

NASDAQ:SELX - Nasdaq - KYG8021C1042 - Common Stock - Currency: USD

1.17  0 (0%)

Fundamental Rating

1

Taking everything into account, SELX scores 1 out of 10 in our fundamental rating. SELX was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. SELX has a bad profitability rating. Also its financial health evaluation is rather negative. SELX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SELX Yearly Net Income VS EBIT VS OCF VS FCFSELX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

The Return On Assets of SELX (0.85%) is comparable to the rest of the industry.
The Return On Equity of SELX (0.91%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.85%
ROE 0.91%
ROIC N/A
ROA(3y)-4.18%
ROA(5y)N/A
ROE(3y)-40.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SELX Yearly ROA, ROE, ROICSELX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SELX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SELX Yearly Profit, Operating, Gross MarginsSELX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -50 -100 -150 -200

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for SELX has been increased compared to 1 year ago.
The debt/assets ratio for SELX is higher compared to a year ago.
SELX Yearly Shares OutstandingSELX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
SELX Yearly Total Debt VS Total AssetsSELX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B

2.2 Solvency

SELX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
SELX has a Debt to Equity ratio of 0.00. This is in the better half of the industry: SELX outperforms 70.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
SELX Yearly LT Debt VS Equity VS FCFSELX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.11 indicates that SELX may have some problems paying its short term obligations.
SELX has a worse Current ratio (0.11) than 99.09% of its industry peers.
A Quick Ratio of 0.11 indicates that SELX may have some problems paying its short term obligations.
SELX has a worse Quick ratio (0.11) than 99.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
SELX Yearly Current Assets VS Current LiabilitesSELX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

SELX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -306.17%.
EPS 1Y (TTM)-306.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8043.2%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SELX Yearly Revenue VS EstimatesSELX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
SELX Price Earnings VS Forward Price EarningsSELX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SELX Per share dataSELX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SELX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEMILUX INTERNATIONAL LTD

NASDAQ:SELX (7/11/2025, 8:00:02 PM)

1.17

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.8%
Inst Owner Change0%
Ins Owners1.31%
Ins Owner ChangeN/A
Market Cap43.79M
AnalystsN/A
Price TargetN/A
Short Float %0.12%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 0.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.18%
ROA(5y)N/A
ROE(3y)-40.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-306.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8043.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-256.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-262%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.24%
OCF growth 3YN/A
OCF growth 5YN/A